StockData
APLMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as APLMW

Apollomics Inc.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 24, 2026
$22.05+0.95 (+4.49%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Apollomics statistics

Financials through Dec 31, 2025, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison

Valuation

MeasureApollomicsIndustry median
Market Cap$48.42M$166.30M
Enterprise Value$45.14M$88.19M
PS Ratio5.703.65

Enterprise value

MeasureApollomicsIndustry median
EV / Sales5.312.51

Income (trailing twelve months)

MeasureApollomicsIndustry median
Revenue$8.50M$58.34M
Pretax Income-$10.94M-$14.34M
EPS (Diluted)-$7.57-$0.83

Margins

MeasureApollomicsIndustry median
Pretax Margin-128.7%-13.3%

Balance sheet

MeasureApollomicsIndustry median
Cash & Short-Term Investments$3.28M$61.43M
Net Cash (Debt)$3.28M$15.35M
Net Cash Per Share$1.49$0.66
Working Capital-$275.00K$76.81M

Financial position

MeasureApollomicsIndustry median
Current Ratio0.963.34
Quick Ratio0.882.44

Cash flow (trailing twelve months)

MeasureApollomicsIndustry median
Operating Cash Flow-$10.37M-$12.35M

Efficiency

MeasureApollomicsIndustry median
Asset Turnover0.860.39
Revenue Per Employee$607.14K$404.87K
Employee Count1474

Shares

MeasureApollomicsIndustry median
Shares Outstanding2,196,05058,127,000
Shares Change (YoY)41.8%10.9%
Float527,75349,136,700
Shares Held by Insiders76.0%11.6%

Taxes

MeasureApollomicsIndustry median
Income Tax$3.00K$79.87K

Calculated by StockData from Apollomics's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.